Medical Condition News

RSS

KemPharm commences KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm’s proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.

22 Oct 2009

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.

22 Oct 2009

Helix Hearing Care Centre's initiative to increase hearing healthcare awareness

Helix Hearing Care Centre, a subsidiary of Lifestyle Hearing Corporation, has recently signed a sponsorship agreement with the Ottawa Senators. They are now the Official Hearing Care Company of one of Canada's most-loved hockey teams.

22 Oct 2009

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

The United States Bone and Joint Decade (USBJD) today announces that as part of its 2009 Advocacy Day nearly 80 musculoskeletal patients and patient advocates from across the nation are participating in more than 175 Congressional visits. Patients and their advocates -- physicians, family members and USBJD participating partners -- are raising awareness of the huge burden that musculoskeletal conditions plays on the U.S. These conditions are some of the most costly, common, and disabling conditions to date.

22 Oct 2009

Drugs affecting the central nervous system effective against fibromyalgia, study finds

People suffering from fibromyalgia have reduced activity in the parts of the brain that inhibit the experience of pain. Drugs that affect the CNS can be effective against the disease, and are thought to be even more so if administered early in its course. This according to a new thesis from the Swedish medical university Karolinska Institutet.

22 Oct 2009

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

GeneNews Limited, a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced the publication of a paper in the Journal of Clinical Gastroenterology. The paper reports data using GeneNews' proprietary Sentinel Principle(R) platform technology to identify complex changes in blood gene expression patterns that were differentially regulated between active and inactive Crohn's disease.

22 Oct 2009

Faster insulin absorption for varying insulin doses and PH20 concentrations demonstrated

Halozyme Therapeutics, Inc. today announced dose response study results that demonstrated faster insulin absorption and increased peak insulin concentrations after co-administration of its recombinant hyaluronidase enzyme (rHuPH20 or PH20) with regular human insulin and with insulin lispro. The enhanced absorption effects were observed at clinically relevant insulin doses across a broad range of PH20 concentrations.

22 Oct 2009

Cold laser relieves pain and accelerates healing of muscle injuries

Acupuncture is widely acclaimed for relieving pain. However, many people would rather endure the crushing pain of migraine headaches than face their fear of needles. Nicholas C. Steadman, L.Ac., who practices acupuncture in New York City, claims to have erased that barrier with the use of cold laser acupuncture.

22 Oct 2009

Pilot study examines the concordance of Quotient ADHD Test

BioBehavioral Diagnostics Company announced today that their poster has been accepted through a rigorous peer-review process for inclusion as a New Research Poster presentation at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry (AACAP) in Honolulu, HI, October 27-November 1, 2009.

22 Oct 2009

The Melting Pot Restaurants' initiative for cancer research

The Melting Pot Restaurants join St. Jude Children’s Research Hospital in the sixth annual Thanks and Giving campaign from Oct. 31 – Dec. 5 to “give thanks for the healthy kids in your life, and give to those who are not” by donating a portion of proceeds to cancer research.

22 Oct 2009

Peripheral arterial disease linked to lifestyle changes

Modifying the risk of peripheral arterial disease (or PAD)-with healthy lifestyle changes-remains vital to one's health, note researchers in a recent issue of the Journal of Vascular and Interventional Radiology. And while PAD can progress and worsen over time, there is not enough evidence yet to advocate minimally invasive treatment in patients who have had a narrowing or blockage of a leg artery but showing no signs or symptoms of the disease, say Irish researchers in a retrospective study of more than 900 individuals.

22 Oct 2009

Highlights of Cell Therapeutics' pixantrone study to be presented at the Lymphoma and Myeloma Conference

Cell Therapeutics, Inc. announced that Dr. Richard Van der Jagt of the Ottawa General Hospital will present at the Lymphoma and Myeloma 2009 Conference in New York an overview of CTI's pixantrone phase II and phase III clinical studies that demonstrated high rates of complete remission (CR) in relapsed/refractory aggressive and indolent non-Hodgkin's lymphoma (NHL) patients.

22 Oct 2009

Short-listed companies to submit proposals for chronic disease management system

eHealth Ontario and Infrastructure Ontario today announced the three companies short-listed to submit proposals for a chronic disease management system that will be used initially to establish a Diabetes Registry for Ontarians and an eHealth Portal framework.

22 Oct 2009

Obese women retain half of post pregnancy weight

Obese women who gain more than the recommended amount during pregnancy are much more likely to retain a portion of that weight one year after they give birth, according to a Kaiser Permanente study published in the November issue of Obstetrics & Gynecology.

22 Oct 2009

Study explores aldosterone antagonist usage among US patients hospitalised with heart failure

A study published today in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated.

22 Oct 2009

New study on the factors that determine development of posttraumatic stress disorder

After exposure to extreme life stresses, what distinguishes the individuals who do and do not develop posttraumatic stress disorder (PTSD)? A new study, published in the October 1st issue of Biological Psychiatry, suggests that it has something to do with the way that we control the activity of the prefrontal cortex, a brain region thought to orchestrate our thoughts and actions.

22 Oct 2009

Researchers develop a new test process for cancer drugs

It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Researchers at the Heinz Nixdorf Chair for Medical Electronics at the Technische Universitaet Muenchen (TUM) have developed a new test process for cancer drugs.

22 Oct 2009

Clinical performance study reveals the accuracy and precision of TRUE2go system

Home Diagnostics, Inc., a leading developer, manufacturer, and marketer of blood glucose monitoring systems, today announced the results of a TRUE2go™ clinical performance study published in the October 2009 issue of the journal Diabetes Technology & Therapeutics. The study, “Clinical Performance of the TRUE2go Blood Glucose System – A Novel Integrated System for Meter and Strips,” demonstrated the accuracy and precision of the TRUE2go system and found that it was both easy and convenient to use by patients.

22 Oct 2009

Plant-based foods could help fight obesity and heart disease

The cheeseburger and French fries might look tempting, but eating a serving of broccoli or leafy greens first could help people battle metabolic processes that lead to obesity and heart disease, a new University of Florida study shows.

22 Oct 2009

People in developing countries spend 90% of all medical expenditures for diabetes care

Type 2 diabetes is often seen as a condition affecting older, unproductive adults in wealthy countries. However, the reality is that 70% of people with diabetes now live in low and middle-income countries and the economic impact of diabetes is much greater in poorer countries.

22 Oct 2009

Medical Condition News

KemPharm commences KP106 Phase 1 clinical trial for ADHD

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Helix Hearing Care Centre's initiative to increase hearing healthcare awareness

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

Drugs affecting the central nervous system effective against fibromyalgia, study finds

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

Faster insulin absorption for varying insulin doses and PH20 concentrations demonstrated

Cold laser relieves pain and accelerates healing of muscle injuries

Pilot study examines the concordance of Quotient ADHD Test

The Melting Pot Restaurants' initiative for cancer research

Peripheral arterial disease linked to lifestyle changes

Highlights of Cell Therapeutics' pixantrone study to be presented at the Lymphoma and Myeloma Conference

Short-listed companies to submit proposals for chronic disease management system

Obese women retain half of post pregnancy weight

Study explores aldosterone antagonist usage among US patients hospitalised with heart failure

New study on the factors that determine development of posttraumatic stress disorder

Researchers develop a new test process for cancer drugs

Clinical performance study reveals the accuracy and precision of TRUE2go system

Plant-based foods could help fight obesity and heart disease

People in developing countries spend 90% of all medical expenditures for diabetes care

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News